Makiko Taniai
- Hepatology top 0.5%
- Liver Disease and Transplantation 22
- Liver Diseases and Immunity 16
- Hepatocellular Carcinoma Treatment and Prognosis 13
- Hepatitis C virus research 12
- Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment 65
- Hepatitis B Virus Studies 10
-
- Diet, Metabolism, and Disease 24
-
- Alcohol Consumption and Health Effects 19
- Cell Biology top 5%
- Co-authors
- Katsutoshi TokushigeEtsuko HashimotoGregory J. GoresAli CanbayKeiko ShiratoriAriel E. FeldsteinSatoru YatsujiLawrence J. Burgart
- Partner nations
- JapanUnited StatesNorway
In The Last Decade
Makiko Taniai
92 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Hepatology 1.8k
- Epidemiology 3.3k
- Endocrinology, Diabetes and Metabolism 937
- Pathology and Forensic Medicine 526
- Cell Biology 452
Countries citing papers authored by Makiko Taniai
This map shows the geographic impact of Makiko Taniai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makiko Taniai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makiko Taniai more than expected).
Fields of papers citing papers by Makiko Taniai
This network shows the impact of papers produced by Makiko Taniai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makiko Taniai. The network helps show where Makiko Taniai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Makiko Taniai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 8 | |
| 2 | 2023 | 8 | |
| 3 | 2020 | 6 | |
| 4 | 2019 | 42 | |
| 5 | 2018 | 12 | |
| 6 | 2018 | 15 | |
| 7 | 2016 | 0 | |
| 8 | 2015 | 6 | |
| 9 | 2015 | 5 | |
| 10 | 2014 | 4 | |
| 11 | 2011 | 14 | |
| 12 | 2009 | 231 | |
| 13 | 2008 | 259 | |
| 14 | 2005 | 85 | |
| 15 | 2004 | 31 | |
| 16 | 2003 | 165 | |
| 17 | 2000 | 1 | |
| 18 | 1999 | 1 | |
| 19 | 1993 | 89 | |
| 20 | 1992 | 1 |
About Makiko Taniai
Makiko Taniai is a scholar working on Hepatology, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 95 papers that have together received 4.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (65 papers), Diet, Metabolism, and Disease (24 papers), Liver Disease and Transplantation (22 papers), Alcohol Consumption and Health Effects (19 papers), Liver Diseases and Immunity (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Hepatitis C virus research (12 papers) and Hepatitis B Virus Studies (10 papers). The work is most often cited by research in Hepatology (1.8k citations), Epidemiology (3.3k citations) and Endocrinology, Diabetes and Metabolism (937 citations). Makiko Taniai has collaborated with scholars based in Japan, United States and Norway. Frequent co-authors include Katsutoshi Tokushige, Etsuko Hashimoto, Gregory J. Gores, Ali Canbay, Keiko Shiratori, Ariel E. Feldstein, Satoru Yatsuji, Lawrence J. Burgart, Hajime Higuchi and Paul Angulo. Their work appears in journals such as Journal of Clinical Investigation, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.